Island Pharmaceuticals Ltd (ILA) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.237x

Based on the latest financial reports, Island Pharmaceuticals Ltd (ILA) has a cash flow conversion efficiency ratio of -0.237x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.69 Million ≈ $-1.20 Million USD) by net assets (AU$7.16 Million ≈ $5.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Island Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Island Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Island Pharmaceuticals Ltd carry for a breakdown of total debt and financial obligations.

Island Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Island Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Crown Confectionery Co Ltd KO:264900	0.015x
Hwacheon Machi KO:010660	-0.024x
Hunya Foods Co Ltd TW:1236	0.036x
Critical Elements Corporation V:CRE	-0.036x
Oswal Agro Mills Limited NSE:OSWALAGRO	0.000x
Seco/Warwick SA WAR:SWG	-0.098x
Solborn Inc KQ:035610	-0.027x
Pearl Diver Credit Company Inc. NYSE:PDCC	-0.158x

Annual Cash Flow Conversion Efficiency for Island Pharmaceuticals Ltd (2019–2024)

The table below shows the annual cash flow conversion efficiency of Island Pharmaceuticals Ltd from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see ILA stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$7.16 Million ≈ $5.06 Million	AU$-2.77 Million ≈ $-1.96 Million	-0.387x	+81.44%
2023-12-31	AU$1.52 Million ≈ $1.07 Million	AU$-3.16 Million ≈ $-2.24 Million	-2.084x	-37.34%
2022-12-31	AU$1.79 Million ≈ $1.26 Million	AU$-2.71 Million ≈ $-1.92 Million	-1.517x	-248.92%
2021-12-31	AU$4.32 Million ≈ $3.06 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.435x	-196.57%
2020-12-31	AU$6.40 Million ≈ $4.53 Million	AU$-938.24K ≈ $-663.86K	-0.147x	-702.06%
2019-12-31	AU$-657.00 ≈ $-464.87	AU$-16.00 ≈ $-11.32	0.024x	--

About Island Pharmaceuticals Ltd

AU:ILA Australia Biotechnology

Market Cap

$70.44 Million

AU$99.55 Million AUD

Market Cap Rank

#20549 Global

#709 in Australia

Share Price

AU$0.37

Change (1 day)

+0.00%

52-Week Range

AU$0.13 - AU$0.57

All Time High

AU$0.57